Drug Controversies and Demonization
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
International Narcotics Control Strategy Report
United States Department of State Bureau for International Narcotics and Law Enforcement Affairs International Narcotics Control Strategy Report Volume I Drug and Chemical Control March 2017 INCSR 2017 Volume 1 Table of Contents Table of Contents Common Abbreviations ............................................................................................................................. iii International Agreements .......................................................................................................................... v INTRODUCTION ........................................................................................................................................... 1 Policy and Program Developments ......................................................................................................... 17 Overview ................................................................................................................................................. 18 Methodology for U.S. Government Estimates of Illegal Drug Production ............................................... 24 (with dates ratified/acceded) ................................................................................................................... 30 USG Assistance ..................................................................................................................................... 36 International Training ............................................................................................................................. -
PSYC 165) Fall 2012
Course Syllabus Drugs, Behavior and Society (PSYC 165) Fall 2012 Instructors: John Monterosso TAs: Lectures: Tue & Thur 8:00 – 9:20 pm, SGM Room 124 FINAL EXAM: Tuesday, December 18 4:30-6:30 p.m. {Note that this is late in the final exam period. If you cannot make this date, please do not take this course.} *Minor revisions may be made to the syllabus – when this occurs, a message will be posted on Blackboard. Drug use can be looked at from many perspectives. Although we will consider several, our emphasis will be on a psychological and physiological perspectives. We want you to leave this course with a better understanding of why people use drugs, what effects drugs have on people, and how individuals think about drug use. Besides learning about drugs and their use, we hope you will learn how to critically evaluate scientific research and the benefits (and limitations) of using this research to inform personal choices and public policy. As a Cat 4 GE class, this larger goal is most important. We recognize that use and abuse of drugs is a topic that touches the everyday lives of people, and we hope this will energize the course. However, please do not look to the faculty or TAs for personal and professional opinions or counsel. Information about available resources is on an informational page posted on Blackboard. Readings The primary course text is: Drugs, Society, and Human Behavior. By Carl Hart & Charles Ksir, 2010. McGraw-Hill 14th edition. It is available for Kindle, and there look to be cheaper options to me at Amazon than the bookstore, but I don’t know what the Bookstore buy-back program is (or if there even is one). -
April 16, 2021 Addiction in the News
UC CAR Weekly Newsletter 4.16.2021 Welcome to the weekly newsletter from the Center for Addiction Research! Each newsletter includes highlights from addiction in the news topics, active funding opportunities offered by NIDA/NIAAA, and information about any new publications from CAR members. Please email Jen Rowe ([email protected]) to change your communication preferences. Thank you. Thank you for your interest in the Center for Addiction Research - our mission is to accelerate scientific progress in the prevention and treatment of substance use disorders and their consequences by fostering research collaborations across: 1) UC departments, colleges, and centers including Cincinnati Children’s Hospital Medical Center; 2) Local, regional, and state community and governmental partners; and 3) Other academic institutions and industry." April 16, 2021 Addiction in the News UC/ Regional News Center for Addiction Research to hold Summer Speaker Series The College of Medicine’s Center for Addiction Research will hold a Summer Speaker Series to discuss the innovative work and ongoing projects with the community related to prevention, intervention and treatment. The series is hosted by the Urban Health Pathway of Next Lives Here. Monthly presentations begin in May and run through August. Featured CAR presenters will be Drs. Burlew, Blackard, Lyons and Merhar. (pdf attached) >> Register for any of the presentations The 'Other Epidemic' Of Opioids Rages On Last week, the Ohio Department of Mental Health and Addiction Services announced $13 million in new grants awarded to community organizations trying to reduce opioid overdoses in the state. That's right, another epidemic is still raging while we tap the "refresh" buttons on our browsers hoping for our COVID-19 vaccination appointments. -
Preferred Drug List (PDL) OREGON HEALTH PLAN Trilliumohp.Com
Preferred Drug List (PDL) OREGON HEALTH PLAN TrilliumOHP.com 1-877-600-5472 TTY: 711 MCA_EK16V5 Approved 01/01/2019 OHP-TRIL-17-195 Pharmacy Program Trillium Community Health Plan’s goal is to offer the right drug coverage to our members. We work with doctors and pharmacists to make sure we offer drugs used to treat many conditions and illnesses. Trillium covers prescription and some over the counter drugs when they are ordered by a licensed prescriber. The pharmacy program does not cover all drugs. Some drugs need our prior approval. Some have a limit on the amount of drug that can be given. Sometimes you must get Trillium’s prior approval. Even with approval, we will not pay if you are no longer on OHP or if the treatment isn’t covered by OHP. To be paid, the treatment must follow treatment guidelines. This might include step therapy, meaning trying less costly treatment options first. Medications newly approved by the FDA (Food and Drug Administration) require prior- approval until reviewed by our Pharmacy and Therapeutics Committee. Filling a Prescription You can have your prescriptions filled at a Trillium network pharmacy. At the pharmacy, you will need to give the pharmacist your prescription and your ID card. You can find a pharmacy that is in network by calling a Trillium Member Services Representative at 541-485-2155; Toll Free: 1-877-600-5472, or by using the Find a Provider tool on our website at https://providersearch.trilliumhealthplan.com. You do not have to pay for covered drugs. The Trillium preferred drug list has a large number of brand name and generic drugs on it. -
Perspectives on Opioid and Heroin Use in South Central Pennsylvania
Perspectives on opioid and heroin use in south central Pennsylvania Criminal Justice Trends and initiatives in opioid and heroin abuse: A panel discussion RESEARCH BRIEF The contours of the convened to discuss the issue in 2017-18 Pennsylvania state depth, and to identify current budget (Madej, 2017). problem: Overdose initiatives to address the problem. Narcan is also now widely and death available to citizens over- The panel was comprised of: the-counter. Drug overdoses are the leading Police officers cause of accidental death in the Treatment providers The police officers on the U.S. having surpassed Researchers panel credited equipping shootings and traffic accidents police and other first almost a decade ago (Centers Initiatives responders with Narcan as a for Disease Control and key factor in keeping the opioid overdose death rate Prevention [CDC], 2016). From A key initiative gaining increasing in Pennsylvania from 2014-2015, overdose deaths traction in managing opioid overdose climbing even higher than rose by 11 percent, to 52,404, in Pennsylvania and the greater sixth in the nation, and with roughly 63 percent of region, is the equipping of emergency lauded it as a sort of wonder those deaths involving an medical technicians, police, and other drug. opioid such as heroin, fentanyl, first responders with the opioid or other prescription opioids overdose reversal drug naloxone like Vicodin or Percoset (often (trade name: Narcan), which has been Misconception #1 prescribed legally for routine on the market since 1971. pain management). The Addiction propensity significant increases in drug In 2014, Pennsylvania passed Act overdose deaths were seen While productive discussion 139, which allows first responders ensued, key misconceptions primarily in the northeast, acting at the direction of a health care midwest, and mid-south emerged that were endorsed professional to prescribe Narcan and by several of the panelists. -
FOR IMMEDIATE RELEASE CONTACT Voleine Amilcar 415
FOR IMMEDIATE RELEASE CONTACT Voleine Amilcar 415-356-8383 x 244 [email protected] Mary Lugo 770-623-8190 [email protected] Cara White 843-881-1480 [email protected] For downloadable images, visit pbs.org/pressroom/ THE HOUSE I LIVE IN PREMIERES ON INDEPENDENT LENS ON MONDAY, APRIL 8, 2013 “I’d hate to imply that it’s your civic duty to see The House I Live In, but guess what — it is.” — Ty Burr, The Boston Globe (San Francisco, CA) — Winner of the Grand Jury Prize at the Sundance Film Festival, Eugene Jarecki’s The House I Live In builds a compelling case for the complete failure of America’s war on drugs. For the past forty years, the war on drugs has resulted in more than 45 million arrests, one trillion dollars in government spending, and America’s role as the world’s largest jailer. Yet for all that, drugs are cheaper, purer, and more available than ever. Filmed in more than twenty states, The House I Live In captures heart-wrenching stories from those on the front lines — from the dealer to the grieving mother, the narcotics officer to the senator, the inmate to the federal judge — and offers a penetrating look at the profound human rights implications of America’s longest war. The House I Live In premieres on Independent Lens, hosted by Stanley Tucci, on Monday, April 8, 2013 at 10 PM on PBS (check local listings). The film recognizes drug abuse as a matter of public health, and investigates the tragic errors and shortcomings that have resulted from framing it as an issue for law enforcement. -
Surveillance of Drug Abuse Trends in the State of Ohio January - June 2019
OSAMOSAM OhioOhio Substance Substance Abuse Abuse Monitoring Monitoring Network Network SurveillanceSurveillance of of Drug Drug Abuse Abuse Trends Trends in the State of Ohio January - June 2019 Lake Ashtabula Fulton Lucas Williams Ottawa Geauga Cuyahoga Defiance Henry Wood Sandusky Erie Lorain Trumbull Huron Summit Portage Paulding Seneca Medina Putnam Hancock Mahoning Van Wert Wyandot Crawford Ashland Wayne Stark Columbiana Allen Richland Hardin Marion Mercer Auglaize Holmes Carroll Morrow Tuscarawas Jefferson Logan Knox Shelby Union Delaware Coshocton Harrison Champaign Darke Licking Miami Guernsey Belmont Franklin Muskingum Clark Madison Montgomery Preble Fairfield Perry Noble Monroe Greene Pickaway Fayette Morgan Hocking Washington Butler Warren Clinton Ross Athens Vinton Hamilton Highland Clermont Pike Meigs Jackson Brown Adams Scioto Gallia Lawrence Legend Akron-Canton region Columbus region Athens region Dayton region Cincinnati region Toledo region Cleveland region Youngstown region Ohio Substance Abuse Monitoring Network Surveillance of Drug Abuse Trends in the State of Ohio January - June 2019 Prepared by: Ohio Department of Mental Health and Addiction Services Office of Quality, Planning and Research R. Thomas Sherba, OSAM Principal Investigator — PhD, MPH, LPCC Sarah Balser, OSAM Coordinator — MPH, MSW, LSW, CHES Jessica Linley, OSAM Quantitative Data Analyst — PhD, MSW, LSW Table of Contents OSAM-O-Gram....................................................................................................................................................................3 -
The Drugs of War—Captagon and the Islamic State
REPORT CRIMINAL JUSTICE The Drugs of War—Captagon and the Islamic State APRIL 15, 2016 — PATRICK RADDEN KEEFE PAGE 1 One perennial challenge of writing about illicit narcotics is the dearth of hard data. While drug-trafficking organizations often maintain scrupulous records of their transactions, they have a pronounced disincentive to open these books to outsiders. And for a variety of reasons, the media, the counterdrug law-enforcement establishment, and elected political leaders all have incentives to overplay the problem. In a dismayingly typical scenario, drug warriors will fill this information vacuum by conjuring up back-of-the-envelope figures, which the press will then gleefully repeat—at which point, the drug warriors will seek a budget increase, citing the press account, which has now accorded their data points the aura of established fact. (This configuration of mutually affirming incentives is sometimes described—by federal bureaucrats who are clear-eyed enough to admit it—as a self- licking ice cream cone.) If there is fog in the drug war, there is more still in the actual armed conflagration that has consumed Syria, which is now entering its fifth year. And the violent fluidity of this conflict makes it all the more difficult to assess a wave of reports over the past several years about the significance of a little pill known as Captagon—an amphetamine that is said to play a significant part in the civil war. According to numerous accounts, Captagon has become immensely popular with the fighters of the Islamic State. According to numerous accounts, Captagon has become immensely popular with the fighters of the Islamic State. -
April 9, 2021 Addiction in the News
UC CAR Weekly Newsletter 4.9.2021 Welcome to the weekly newsletter from the Center for Addiction Research! Each newsletter includes highlights from addiction in the news topics, active funding opportunities offered by NIDA/NIAAA, and information about any new publications from CAR members. Please email Jen Rowe ([email protected]) to change your communication preferences. Thank you. Thank you for your interest in the Center for Addiction Research - our mission is to accelerate scientific progress in the prevention and treatment of substance use disorders and their consequences by fostering research collaborations across: 1) UC departments, colleges, and centers including Cincinnati Children’s Hospital Medical Center; 2) Local, regional, and state community and governmental partners; and 3) Other academic institutions and industry." April 9, 2021 Addiction in the News UC/ Regional News Opinion: Our society often punishes individuals struggling with addiction The recent settlement announced between the state of Ohio and consulting business McKinsey & Co. for the firm's role in creating and fueling the opioid epidemic is a perfect example of how we unfairly punish Ohioans dealing with substance-use disorder while allowing the engineers of this crisis to escape with just a slap on the wrist. More than 200,000 lives have been lost to the opioid… The Opioid Crisis Was America’s Epidemic Before COVID. Research Suggests that Overdoses Hurt Student Achievement Long before the emergence of COVID-19, the United States was struggling to contain a years-long opioid crisis that took tens of thousands of lives every year. Now, with Oxycontin manufacturer Purdue Pharma still negotiating billion-dollar penalties for its role in the two-decade drug epidemic, experts have begun taking the measure of its impact on student learning. -
Recognizing Drug Use in Adolescents
RecognizingRecognizingRecognizing DrugDrugDrug UseUseUse ininin AdolescentsAAdolescentsdolescents A Quick Guide for Caregivers and Adults 1 RecognizingRecognizing DrugDrug UseUse inin AdolescentsAdolescents A Quick Guide for Caregivers and Adults Concerned caregivers and adults play an important role in ensuring that youth receive adequate help. However, at times it is hard to tell that youth are developing a problem with alcohol and drugs. This guide summarizes the signs of intoxication, use, and abuse commonly reported by substance users. It is important to recognize, however, that some of the behaviors and experiences described in this booklet may also be present among adolescents who are not using substances. For this reason, when deciding on the best course of action to obtain help for your teenager, make sure to talk with your teenager, gather as much information as possible, and consult with health professionals available in your community. i Alcohol and drug use poses significant risks for the healthy development of adolescents, yet substances of abuse are often readily accessible at school, at home, and in the community. This guide has been developed to facilitate early identification of substance use problems in youth. Included is information about common drugs of abuse and key information to help identify youth at risk. Recognizing the signs of use includes how a teenager might look, act, and feel while intoxicated as well as drug para- phernalia and language associated with each drug. g Signs of intoxication vary by type of -
Cleveland Region OSAM Ohio Substance Abuse Monitoring Network
Surveillance of Drug Abuse Trends in the Cleveland Region OSAM Ohio Substance Abuse Monitoring Network Drug Abuse Trends in the Cleveland Region Regional Epidemiologist: Kathryn A. Coxe, MSW, LSW Data Sources for the Cleveland Region This regional report was based upon qualitative data collected via focus group interviews. Participants were active and recovering drug users recruited from alcohol and other drug treatment programs in Cuyahoga, Medina and Wayne counties. Data triangulation was achieved through comparison of participant data to qualitative data collected from regional community professionals (treatment providers and law enforcement) via focus group interviews, as well as to data surveyed from the Cuyahoga County Medical Examiner’s Office, the Lake County Crime Lab, the Ohio Bureau of Criminal Investigation (BCI) and the Ohio Department of Public Safety (ODPS), which logs drug task force seizures from across Ohio. All secondary data are summary data of cases processed from July through OSAM Staff: December 2017. In addition to these data sources, Ohio media outlets were queried for information regarding R. Thomas Sherba, PhD, MPH, LPCC regional drug abuse for January through June 2018. OSAM Principal Investigator Note: OSAM participants were asked to report on drug use/ Kathryn A. Coxe, MSW, LSW knowledge pertaining to the past six months prior to the interview; OSAM Coordinator thus, current secondary data correspond to the reporting period of participants. Jessica Linley, PhD, MSW, LSW OSAM Quantitative Data Analyst OSAMOSAM -
Safe Handling and Disposal of Chemicals Used in the Illicit Manufacture of Drugs
Vienna International Centre, PO Box 500, 1400 Vienna, Austria Tel.: (+43-1) 26060-0, Fax: (+43-1) 26060-5866, www.unodc.org Guidelines for the Safe handling and disposal of chemicals used in the illicit manufacture of drugs United Nations publication USD 26 Printed in Austria ISBN 978-92-1-148266-9 Sales No. E.11.XI.14 ST/NAR/36/Rev.1 V.11-83777—September*1183777* 2011—300 Guidelines for the Safe handling and disposal of chemicals used in the illlicit manufacture of drugs UNITED NATIONS New York, 2011 Symbols of United Nations documents are composed of letters combined with figures. Mention of such symbols indicates a reference to a United Nations document. ST/NAR/36/Rev.1 UNITED NATIONS PUBLICATION Sales No. E.11.XI.14 ISBN 978-92-1-148266-9 eISBN 978-92-1-055160-1 © United Nations, September 2011. All rights reserved. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Requests for permission to reproduce this work are welcomed and should be sent to the Secretary of the Publications Board, United Nations Headquarters, New York, N.Y. 10017, U.S.A. or also see the website of the Board: https://unp.un.org/Rights.aspx. Governments and their institutions may reproduce this work without prior authoriza- tion but are requested to mention the source and inform the United Nations of such reproduction.